Why the study?
Brown adipose tissue has potential for managing metabolic syndrome risk factors, and MRI technologies for detecting and characterizing it have rapidly developed.
MRI technologies for detecting and characterizing brown adipose tissue have developed rapidly, offering a noninvasive method to study its potential in managing metabolic syndrome.
MRI advances expand noninvasive BAT assessment; clinical translation in metabolic syndrome remains unproven.
Metabolic syndrome is presently becoming a global health concern. Brown adipose tissue (BAT) has the potential for managing the risk factors of metabolic syndrome by adjusting plasma lipids and glucose. Magnetic resonance imaging (MRI) is a noninvasive and radiation-free imaging modality for BAT research and clinical applications in both animals and humans. In the past decade, MRI technologies for detecting and characterizing BAT have developed rapidly, with progress in MRI sequencing and the emerging understanding of BAT. In this review, we focus on the main MRI methods for BAT including currently used imaging techniques and new methods and their implications for the symptoms and complications of metabolic syndrome. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY STAGE: 2.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: